How does antifungal pharmacology differ for mucormycosis versus aspergillosis?. Lewis, R. E., Lortholary, O., Spellberg, B., Roilides, E., Kontoyiannis, D. P., & Walsh, T. J. Clinical Infectious Diseases, 54(SUPPL. 1):S67–S72, 2012. Cited by: 52; All Open Access, Bronze Open Access, Green Open Access
How does antifungal pharmacology differ for mucormycosis versus aspergillosis? [link]Paper  doi  bibtex   
@ARTICLE{Lewis2012S67,
	author = {Lewis, Russell E. and Lortholary, Olivier and Spellberg, Brad and Roilides, Emmanuel and Kontoyiannis, Dimitrios P. and Walsh, Thomas J.},
	title = {How does antifungal pharmacology differ for mucormycosis versus aspergillosis?},
	year = {2012},
	journal = {Clinical Infectious Diseases},
	volume = {54},
	number = {SUPPL. 1},
	pages = {S67–S72},
	doi = {10.1093/cid/cir884},
	url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855864796&doi=10.1093%2fcid%2fcir884&partnerID=40&md5=973083cf5094912b65c4f2961c4c5823},
	type = {Article},
	publication_stage = {Final},
	source = {Scopus},
	note = {Cited by: 52; All Open Access, Bronze Open Access, Green Open Access}
}

Downloads: 0